Rebecca Bascom

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Bacterial Endotoxin Is an Active Component of Cigarette Smoke

Jeffrey D. Hasday, Rebecca Bascom, Joseph J. Costa et al. · CHEST Journal · 1999 · 387 citations

Microbial Toxin, Tobacco Control, Nicotine +3

Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment

Rebecca Bascom, Michael Wachs, Robert M. Naclerio et al. · Journal of Allergy and Clinical Immunology · 1988 · 308 citations

Asthma, Inflammation, Nasal Antigen Challenge +11

The Influx of Inflammatory Cells into Nasal Washings during the Late Response to Antigen Challenge: Effect of Systemic Steroid Pretreatment

Rebecca Bascom, Ulf Pipkorn, Lawrence M. Lichtenstein et al. · American Review of Respiratory Disease · 1988 · 285 citations

Asthma, Allergy Medicine, Immunology +19

Cyclooxygenase Metabolism of Endogenous Arachidonic Acid by Cultured Human Tracheal Epithelial Cells

Laurie Churchill, Floyd H. Chilton, James H. Resau et al. · American Review of Respiratory Disease · 1989 · 198 citations

Asthma, Pge2 Production, Inflammatory Lung Disease +17